1-2 of 2
Ana Santaballa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)

Beatriz Tavira, Teresa Iscar, Luis Manso, Ana Santaballa, Marta Gil-Martin, Yolanda García García, Margarita Romeo, Maria Iglesias, Ana de Juan Ferré, María Pilar Barretina-Ginesta, Aranzazu Manzano, Lydia Gaba, María Jesús Rubio, Carlos E. de Andrea, Antonio González-Martín
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 176–186.
https://doi.org/10.1158/1078-0432.CCR-23-0771
Published: 05 January 2024
View articletitled, Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)
Open the PDF for Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study) in another window
Includes: Supplementary data
Journal Articles

Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial

Joan Albanell, José Manuel Pérez-García, Miguel Gil-Gil, Giuseppe Curigliano, Manuel Ruíz-Borrego, Laura Comerma, Joan Gibert, Meritxell Bellet, Begoña Bermejo, Lourdes Calvo, Juan de la Haba, Enrique Espinosa, Alessandro Marco Minisini, Vanesa Quiroga, Ana Santaballa Bertran, Leonardo Mina, Beatriz Bellosillo, Federico Rojo, Silvia Menéndez, Miguel Sampayo-Cordero, Crina Popa, Andrea Malfettone, Javier Cortés, Antonio Llombart-Cussac
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (1): 67–80.
https://doi.org/10.1158/1078-0432.CCR-22-1281
Published: 04 January 2023
View articletitled, Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial
Open the PDF for Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial in another window
Includes: Supplementary data